golgin 97 inhibitors encompass a diverse assortment of compounds meticulously designed to interact with and modulate the activity of golgin 97, also referred to as GM130. This protein serves as a vital component localized within the Golgi apparatus, a pivotal organelle engaged in intricate processes like protein processing and trafficking. Inhibitors within this class are strategically engineered to exert an influential grip on golgin 97, with the ability to impact its multifaceted role in sustaining Golgi structural integrity and functional dynamics.
The mechanisms through which golgin 97 inhibitors exert their effects are multifaceted. These compounds are astutely crafted to interact with specific domains of golgin 97 or its intricate network of binding partners. By engaging with these critical components, inhibitors disrupt the orchestration of golgin 97's interactions within the Golgi environment. Consequently, this disruption can have far-reaching consequences, affecting the Golgi's fundamental organization and the precise orchestration of protein transport mechanisms. Structurally, golgin 97 inhibitors showcase an array of chemical architectures that mirror the intricacies of their targets. This diversity encompasses synthetic compounds that possess the precision to engage with golgin 97's binding pockets, as well as naturally derived molecules that exhibit an affinity for Golgi-localized interactions. The structural versatility inherent in this class speaks to the sophisticated design strategies employed to manipulate golgin 97's role in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore agent that has been reported to disrupt Golgi morphology and affect protein transport by interfering with golgin 97 and other Golgi-related proteins. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a well-known Golgi-disrupting agent that interferes with vesicle trafficking and transport between the endoplasmic reticulum (ER) and the Golgi apparatus, potentially affecting golgin 97 interactions. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Golgicide A is a compound that specifically disrupts the integrity of the Golgi apparatus by targeting golgin 97, leading to Golgi fragmentation and inhibition of cellular processes relying on Golgi functions. | ||||||